7 days ago2 minProteona opens new laboratory in SingaporeNew facility will also serve as regional headquarters for Singleron in Asia Singapore, May 11, 2022 - Proteona Pte. Ltd., a subsidiary of...
7 days ago1 minOpen Calls for TRANSVAC2 Vaccine Development Services: Apply Now!Vaccine Development Services: Deadline May 31st, 2022 Developing a vaccine is a time-consuming and complex process, requiring a...
Apr 223 minAvantor non-exclusive distributor in the U.S.A. Viscofan BioEngineering announces Avantor as a non-exclusive distributor for their collagen research biomaterials in the U.S.A. Weinheim,...
Apr 213 minAffimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid ...
Apr 211 minMatthias Hentze receives Centenary AwardThe Biochemical Society recognises Hentze’s contributions in RNA Biology Each year the Biochemical Society awards the Centenary Award to...
Mar 253 minCELONIC to become a long-term partner of the Federal Republic of Germany for vaccine supplyHeidelberg, Germany, March 24th 2022 – The Federal Republic of Germany has announced its decision to sign contracts with Celonic AG and...
Mar 222 minUǧur Șahin establishes scientific department at HI-TRON MainzThe immunologist, cancer researcher and entrepreneur Uǧur Șahin is establishing a scientific department for mRNA-based cancer ...
Mar 222 minChromatography under controlA new method monitors chromatographic filtration in real time and enables continuous process control. Nowadays, biopharmaceuticals such...
Mar 222 minVERAXA Biotech GmbH Appoints Dr. Lars Hufnagel to Chief Technical OfficerLars Hufnagel will be responsible for advancing VERAXA’s antibody screening and ADC technologies by further developing its ...
Mar 152 minBioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunologyResearch team ‘TDA’ to examine ‘Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging’ With this project, the partners launch...
Mar 155 minNEC OncoImmunity erwirbt VAXIMMs Neoantigen-Impfstoffprojekte zur weiteren Entwicklung VAXIMM-Technologie ermöglicht schnelle Generierung und Bereitstellung personalisierter T-Zell-Krebs-Impfstoffe und könnte wesentliche...
Mar 157 minAscendis Pharma A/S Announces Phase 3 PaTHway Trial of TransCon™ PTH in Adults with Hypoparathyroid– For the primary composite endpoint, TransCon PTH demonstrated a response rate of 78.7% compared to 4.8% for control (p-value...
Mar 92 minSingleron Acquires ProteonaSingleron further extends reach outside China and strengthens its expertise in translational and clinical research Nanjing, China;...
Mar 54 minHeidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity InvestmentHeidelberg Pharma grants Huadong exclusive license to develop and commercialize HDP-101 and HDP-103 in Asia (excluding Japan), plus...
Mar 32 minBioMed X Institute and Boehringer Ingelheim start new research project in brain sensor developmentResearch team ‘BDB’ to develop an advanced biosensor for pharmacological monitoring in the brain Fifth joint reseach project of the...
Feb 122 minEMBL and Latvia deepen collaborationAgreement signed with Latvia’s Biomedical Research and Study Centre will boost academic exchange and collaboration on some of the largest...
Feb 123 minGermany and France intend to commit €1 billion each for new European Tech Champions InitiativeGermany and France represented by Christian Lindner, Federal Minister of Finance, Robert Habeck, Federal Minister for Economic Affairs...
Feb 121 minAGC Biologics Supports BioNTech Omicron-based Vaccine Candidate with pDNA Starting MaterialAGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced an expanded...
Dec 19, 20212 minAION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial IntelligenceAION Labs, Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS), to start second...
Nov 21, 20212 minOwkin becomes ’unicorn’ with $180m investment from Sanofi and four new collaborative projectsOwkin and Sanofi are delighted to announce that Owkin is now a ‘unicorn’ – a startup valued at more than $1 billion – through a new $180...